Brief: Ventyx Biosciences Reports Fourth Quarter Results

Ventyx Biosciences

23/03/2023 20:06

March 23 (Reuters) - Ventyx Biosciences Inc  VTYX.O :
    * VENTYX BIOSCIENCES REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND HIGHLIGHTS RECENT CORPORATE PROGRESS
    * CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES WERE
$356.6
MILLION AS OF DECEMBER 31, 2022
    * BELIEVE OUR CURRENT CASH, CASH EQUIVALENTS AND MARKETABLE
SECURITIES ARE SUFFICIENT TO FUND OUR PLANNED OPERATIONS INTO
2025
    * QTRLY LOSS PER SHARE $0.62
    * Q4 EARNINGS PER SHARE VIEW $-0.64 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNXc9H1gM 
Further company coverage:  VTYX.O 

 ((Reuters.Briefs@thomsonreuters.com;))